study on the effect of hyoscine on progress of labour and pregnancy outcome

Effect of hyoscine N-Butyl bromide on progress of labour and pregnancy outcome; A randomized control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407805328722

Enrollment

128

Registered

2024-07-29

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labour progress

Interventions

hyoscine butylbromide and water for injection

water for injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women with term pregnancy gravida 1 to gravida 5 2. Those that consented to partake in the study 3. Aged 18 and above 4. Women in active phase of labour 5. Women with no contraindication to drug use 6. Singleton foetus at term 7. Cephalic presentation

Exclusion criteria

Exclusion criteria: 1. Women with contraindication to vaginal delivery 2. Women with any present or past obstetric emergency/complication 3. Intrauterine fetal Death (IUFD) 4. Fully dilated 5. Suspected fetal distress

Design outcomes

Primary

Measure	Time frame
The primary outcomes that will be noticed are the duration of first, second and third stages of labour, cervical dilation rate, the maternal and neonatal side effects. Secondary outcome are postpartum hemorrhage rate, uterine inertia, caesarean section rate, tachycardia and the relationship between the parity of the respondent.	—

Secondary

Measure	Time frame
postpartum hemorrhage rate, uterine inertia and caesarean section rate.	—

Countries

Nigeria

Contacts

Public ContactMuhammad Kabir Bello

public enquiries

drkaybee2013@gmail.com+2348038110845

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026